Rinsho Hyoka(Clinical Evaluation)

Review

Review

year
volume
number
page
article's title
author
1972 1 2,3 137 On a Clause According to Which Investigators be Restricted from Publishing the Results of Clinical Experimentations with Drugs and on the Legal Responsibility of Investigators (Arising from the Above-Mentioned Clause) Tadahiro Mituishi
1974 2 1 3 Concerning consent for clinical trials with drugs and some basic points about its documentation in Japan Tadahiro Mituishi
1974 2 2 133 Clinical Evaluation of Drugs used for the Gastric Ulcer|Present and Future Naokata Shimizu
1974 2 3 327 New Rulemaking for Protection of Human Subjects Involved in Biomedical Research and Drug Test-Established and Proposed in USA Haruo Miyano
1975 3 1 3 Evaluation of Antidepressant Drugs Masanao Kurihara
1975 3 2 127 Re-evaluation of Drugs in Japan Shogo Kuwahara
1975 3 3 281 Clinical Judement Takeo Doi
1975 3 3 289 Clinical Trial and Drug Evaluation for Functional Uterine Bleeding Koichi Yamamoto
1976 4 1 3 Methodological Problems in the Clinical Evaluation of Antianxiety Drugs Hitoshi Itoh
1976 4 2 179 A Review of Electronic Data Processing of intensive Monitoring Systems in the Detection of Adverse Drug Reaction Yorio Satoh
1976 4 3 323 Study on the Clinical Evaluation of Topical Corticosteroids
|
From the Results of Double-blind Tests in Japan
Masaru Ishihara
1977 5 1 3 A Double-blind Controlled Trial Available for Animal Experiment of Cerebrovascular Disease
|
A brief review |
Msakuni Kameyama
1977 5 2 177 A Few Words on Clinical Evaluation of Antihyperlipidemic Drugs Chikayuki Naito
1977 5 3 457 Medical Treatment of Cataract Akira Nakajima
1978 6 1 3 Drug Treatment for the Aged Patients |A critical review| Msakuni Kameyama
1978 6 2 135 Evaluations of Drugs Used to Treat the Angina Pectoris Naokata Shimizu
1978 6 3 367 Reflections on a currently developed method according to which it has been attemped to obtain informed consent in a randomized clinical trial with drugs. This method has recently been tried in Japan Tadahiro Mituishi
1979 7 1 3 Drugs and Testicular Toxicity Assessment in Laboratory Animals in Relation to Blood-Tests Barrier Yoshihito Omori
1979 7 2 195 The Problems in Clinical Trial of New Drugs involving Women in Pregnancy or Associated Conditions Koichi Yamamoto
1979 7 3 425 Influence of Age on Final Global Improvement Rating (FGIR) and Overall Safety Rating of Clinical Drug Experiment Msakuni Kameyama
1980 8 1 3 ƒĄ-blocker and Glaucoma Akira Nakajima
1980 8 2 307 Present Status of and Method for Evaluation of Non-steroid Anti-inflammatory Drugs Yutaka Mizushima
1980 8 2 317 On the Labeling of Indication and Usage of the Anti-anxiety Drugs
|Particulary on the Psycosomatic Diseases|
Naokata Shimizu,
Sueharu Tsutsui,
Hiroyuki Suematsu
1980 8 3 535 Data Processing on Survival Problem Using Life Table Yukio Suzuki
1981 9 1 3 A survey on the protection of human rights of subjects involved in clinical trials with new drugs, on the basis of the results of the enquete study conducted by the Medical Division of the Committee on the Protection of Human Rights of the Japan Federatio Tadahiro Mitsuishi,
Eiko Kurisu,
Yorio Satoh
1981 9 2 241 Retrodiction of Final Global Improvement Rating (FGIR) of Depressive Patients under Antidepressant Therapy by their Background and Initial Checked Points of Doctor's and Patient's Rating Scales on Depression Masanao Kurihara
1981 9 3 527 The Lithium Poisoning, Clinical Picture and its Treatment Shosuke Watanabe, Takashi Ebara
1982 10 1 3 On 2~2 Contingency Table Analysis and its Application to Clinical Trials Hiroe Tsubaki
1982 10 3 527 Measures of Association for the 2~2 Contingency Table and their Application to Clinical Trials Toshiharu Fujita,
Hiroe Tsubaki
1983 11 1 3 The Ability of Diagnosis, Therapy and Investigation
|
Phase ‡U Study of New Drug Development|
Yorio Satoh
1983 11 2 253 Some Important Issues of Clinical Trials Chikayuki Naito
1983 11 3 527 Rating Scales for Dementia|Application for evaluating therapeutic efficacy| Hitoshi Itoh,
Taeko Takei,
Mari Tateyama, et al.
1984 12 1 3 Drug Affecting Lactation Yoshihito Omori
1984 12 2 309 On Some Problems with the Widely Used Statistical Procedures for Comparing Drug Effects Chihiro Hirotsu
1984 12 3 589 On Some Problems with the Widely Used Statistical Procedures for Comparing Drug Effects(2) Chihiro Hirotsu
1985 13 1 3 Controversies in Clinical Trials, Informed Consent, and Drug Use During Pregnancy Koichi Yamamoto
1985 13 2 285 Gene Therapy and Immunopharmacology Akira Nakajima
1985 13 3 601 Discrepancy of Results from Different Statistical Tests in Clinical Trials Toshiharu Fujita,
Hiroe Tsubaki
1986 14 1 3 New Focus on the Current Animal Testing in Preclinical Toxicity Tests
|
Perspectives on LD50|
Yoshihito Omori
1986 14 2 221 Therapeutic Response of "Brain Artheriosclerosis" Masanao Kurihara, Toshiharu Fujita
1986 14 3 467 Some Statistical Problems in Clinical Trials(1)
|
Test for the Equivalence of Two Drugs|
Chihiro Hirotsu
1986 14 3 477 Multiplicity in Clinical Trials
|Especially Problems of the Multiple Comparisons Treatments|
Toshiharu Fujita,
Hiroe Tsubaki,
Yorio Satoh
1986 14 4 707 Some Statistical Problems in Clinical Trials(2)
|
Multiplicity of Statistical Tests|
Chihiro Hirotsu
1987 15 1 3 Clincial Evaluation of Anti-dementia Drugs Msakuni Kameyama
1987 15 3 417 Adverse Drug Reactions in Clinical Trials Keiji Ueda
1988 16 1 3 Revision of the Data Processing System on Drug Evaluation Toshiharu Fujita,
Hiroe Tsubaki
1988 16 2 203 Clinical Evaluation of Antianxiety Drugs Sadanori Miura
1988 16 3 411 Therapeutic Response of "Braini-arteriosclerosis"
|
Collective Analysis of the Double-Blind Studies|No.2
Masanao Kurihara, Toshiharu Fujita
1988 16 4 569 Informed Consent as a Proof of Participating in the Joint Work
|
A few comments on clinical trials involving human subjects and on their human rights|
Tadahiro Mituishi
1989 17 1 3 Progress in Clinical Evaluation of Antiarrhythmic Drugs Kazuo Kato
1989 17 2 171 Some Problems on Japanese Good Clinical Practice(Draft)(1) Yorio Satoh
1989 17 3,4 337 Studies on Side Effects of Drug Naokata Shimizu, Toshiharu Fujita
1990 18 1 3 Multiplicity Problem in Comparative Clinical Trial Yorio Satoh,
Chihiro Hirotsu,
Hiroe Tsubaki, et al
1990 18 2 245 Some Problems on Japanise Good Clincial Practice (Draft)(2) Yorio Satoh
1990 18 3 403 Some Statistical Problems and Proposals in Comparative Clincial Trials Chihiro Hirotsu
1990 18 3 425 Basic Concept of Post-Marketing Surveillance, An Application for the Antihypertensive Drugs Naokata Shimizu, Yoshihiro Kaneko,
Yukio Suzuki
1991 19 1 3 International Harmonization of Nonclinical Drug Safety Requirements Yoshihito Omori
1991 19 2 187 Some Problems in Internationalization of Clinical Trials for New Drug Approval Chikayuki Naito
1991 19 2 205 Utility of Drugs and Its Assessments in Clinical Trials Koichi Yamamoto
1991 19 4 427 A Guidance for Drug Therapy in the Elderly Keiji Ueda
1992 20 1 3 A Few Problems Inherent to the Phase ‡T Study in Clinical Evaluation of Drug Efficacy Chikayuki Naito
1992 20 3 417 Concepts on "Usefullness" as a Parameter for Global Evaluation of Drug-effects in the Clinical Trial Naokata Shimizu, Masanao Kurihara, Chikayuki Naito
1993 21 1 3 Some Theoretical and Psychological Considerations on "FGIR" Masanao Kurihara
1993 21 2 155 Pharmacoepidemiology Naokata Shimizu
1994 22 1 3 Global Judgement in the Clincial Trial |Especially, on the Problem of Clinical Utility| Naokata Shimizu,
Yorio Satoh,
Robert Temple, et al
1994 22 1 43 The Tokyo-Yokohama Hypertension Study (TYHS) A Japanese Trial of Prospective Randomized Antihypertensive Treatment Yoshihiro Kaneko
1994 22 2,3 195 Clincal Evaluation of Osteoporosis in Internal Medicine Takuo Fujita
1994 22 2,3 203 Clinical Evaluation of Osteoporosis Tetsuo Inoue
1995 23 1 3 The Present Condition and Problems in the Clinical Evaluation of Anti-HIV Agents Satoshi Kimura
1995 23 3 489 On the Recent Topics in the Comparative Clinical Trials Chihiro Hirotsu
1996 24 1 3 Information Transduction in Biology and Medicine Naokata Shimizu
1997 24 2,3 151 Drug Therapy of Glaucoma Akira Nakajima
1997 25 1 3 Drug Therapy of Glaucoma (2)
|
Glaucoma and Vasoactive Substance (Circulating Hormone)|
Akira Nakajima
1998 25 2,3 119 Constructing a Data Base Useful for a Pharmacological Study Chihiro Hirotsu
1998 25 2,3 149 Supply of Information Required for the Proper Use of Drugs Fumito Tsuchiya
1998 26 2 133 Clinical Evaluation of Antidementia Drugs Akira Homma
2001 29 1 167 Clinical endocrine pharmacology-Including ethnic factors in pharmacodynamics- Naokata Shimizu
2001 29 1 185 EBM questioned-A metascientific criticism Takeo Saio,
Chieko Kurihara
2003 30 2„3 353 Sexual differences and the use of drugs-A review on clinical pharmacology- Naokata Shimizu
2008 36 1 7 Deep Brain Stimulation : History, present status and future development Chikashi Fukaya
2009 37 1 279 Gender and ethnic variability of the clinical pharmacokinetics of transporter substrates ;
|HMG-CoA reductase inhibitors and Angiotensin ‡U receptor antagonists|
Yoshiko Tomita
2011 39 1 31 Right to compensation of volunteers for research-related injuries
|Comparative study and future perspective in view of global clinical trials|
Chieko Kurihara
2013 41 1 241 Application of non-pharmacological physical treatment to treatment-refractory obsessive-compulsive disorder: A critical viewpoint from a psychiatrist Toshihide Kuroki
2014 41 3 597 Regulatory science: An emerging new scientific discipline A. Alan MoghissiC
Roger S. StoughC
Takashi InutsukaCet alD
2017 45 1 35 Lessons learned from the tragic case in Renne Yuji Kumagai
Takeshi Momma

up date 2017/04/25

back to top
back to Rinsho Hyoka (Clinical Evaluation)